Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Amplatzer Amulet China Post Market Study (PMS)

NCT: NCT06189365 · TERMINATED

NCT IDNCT06189365
StatusTERMINATED
Start Date2024-01-30
Completion2025-12-05
SponsorAbbott Medical Devices (INDUSTRY)
First posted
Last updated

Brief Summary

The purpose of this study is to prospectively evaluate the safety and effectiveness of the Amplatzer Amulet LAA occluder in a Chinese patient population indicated for use of this device.

Frequently Asked Questions

What is Amplatzer Amulet China Post Market Study (PMS)?

Amplatzer Amulet China Post Market Study (PMS) is a clinical trial registered under NCT06189365. Current status: TERMINATED.

What is the status of NCT06189365?

The current status of NCT06189365 (Amplatzer Amulet China Post Market Study (PMS)) is: TERMINATED.

When did Amplatzer Amulet China Post Market Study (PMS) start?

Amplatzer Amulet China Post Market Study (PMS) started on 2024-01-30.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑